Categories
- PROTAC Linker
- Protein Control Ligand
- Pathway Inhibitors
- Function Modulators
- Activators
- G Protein-Coupled Receptor Ligands
- Nuclear Receptor Ligands
- GDNF Receptors
- TNF Receptors
- Transcription Factors
- Chemokines
- Cytokine Receptors
- Biomarkers and Buffer Solutions
- Molecular Probes
- Stem Cell Research
- Alzheimer's Disease
- Apoptosis
- Cancer Research
- Epigenetics
- Metabolites
- PET/SPECT Imaging Precursors
- Customized Screening Library
- Ultra Pure Pharmacological Standard
- Tissue Microarray (TMA)
- Proteins and Antibodies
- Primary Cells
- ELISA KIT
- Natural Products
- Lab Equipments
- Humanized Mice for PDX Platform
- Rare Chemicals
- Custom Synthesis
- Antibacterial
- Antifungal
- Antioxidant
- Antiviral
- Molecular Glues
- SARS-CoV
Quantity Discount Table - Order More To Get More Price Discount
| Quantity | mg | Unit Price ($/mg or $/Unit) | Final Price |
|---|---|---|---|
| 1 | 5 | $339.15 | Total: $1,695.75 |
| 1 | 10 | $287.28 | Total: $2,872.80 |
| 1 | 25 | $243.39 | Total: $6,084.75 |
| 1 | 50 | $207.48 | Total: $10,374.00 |
| 1 | 100 | $179.55 | Total: $17,955.01 |
Overview
Clozic (ICI 55897) exhibits reversible anti-proliferative effects and can be used in studies about serving as a potential anti-arthritic agent.
Chemical Properties
| Molecular Formula | C17H17ClO3 |
| Molecular Weight | 304.77 |
| CAS Numbers | 22494-47-9 |
| Solubility | DMSO |
| Purity | 98% by HPLC |
| SMILES Code | C(OC(C(O)=O)(C)C)C1=CC=C(C=C1)C2=CC=C(Cl)C=C2 |
Storage and Handling
0C Short Term, -20C Long Term
References
Foster SJ, et al. Anti-proliferative properties of Clozic, a disease-modifying anti-arthritic agent. Biochem Pharmacol. 1983 Feb 1;32[3] 461-7.